Increased Proliferative Drive of Lymphocytes in Sickle Cell Disease

Introduction Patients with sickle cell disease (SCD) have higher levels of inflammation which plays a prominent role in disease pathogenesis. It is well known that individuals with SCD have a higher erythropoietic drive given the ~20 day life span of their red blood cells. We asked whether this incr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2023-11, Vol.142 (Supplement 1), p.5275-5275
Hauptverfasser: Ginda, Ashley, Zhang, Jingyue, Meng, Wenzhao, Kearns, Charlotte, Weissman, Samuel, Swiggard, Liam, Richards, Clarice, Moore, Jeffrey, Murter, Melissa, Luning Prak, Eline T., O'Doherty, Una
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5275
container_issue Supplement 1
container_start_page 5275
container_title Blood
container_volume 142
creator Ginda, Ashley
Zhang, Jingyue
Meng, Wenzhao
Kearns, Charlotte
Weissman, Samuel
Swiggard, Liam
Richards, Clarice
Moore, Jeffrey
Murter, Melissa
Luning Prak, Eline T.
O'Doherty, Una
description Introduction Patients with sickle cell disease (SCD) have higher levels of inflammation which plays a prominent role in disease pathogenesis. It is well known that individuals with SCD have a higher erythropoietic drive given the ~20 day life span of their red blood cells. We asked whether this increased proliferative drive also occurred in white blood cells (WBC). To characterize WBC turnover we focused on the longest-lived CD4+ and CD8+ T cells. Methods Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient from red cell waste products from consented individuals with sickle cell disease and from leukapheresis products of healthy donors. In ten healthy donors and ten donors with SCD, CD4 and CD8 T cells were purified using EasySep Cell Isolation, labeled with eFluor 670 proliferation dye, and cultured in RPMI with 30% FBS for seven days. Samples were collected daily and stained with naïve and memory T cell markers. CountBright beads were added to obtain absolute cell counts and eFluor 780 live/dead dye was used to capture daily snapshots of cell death. Flow cytometric analysis was performed to track absolute cell numbers, cell division and indirectly monitor cell death. B cells, NK, macrophages, and dendritic cells were similarly tracked. To further probe T cell turnover, T cell receptor (TCR) sequencing was performed on twelve separate aliquots from purified CD4+ T cells at two different timepoints in healthy donors and individuals with SCD. Turnover of clonal sequences was analyzed using the Morisita index. Results CD4+ and CD8+ lymphocytes from individuals with SCD experienced more death in culture by day 7 compared to healthy donor controls. In addition, T lymphocytes from donors with SCD were observed to undergo 15-fold more proliferation compared to healthy donors (p=0.0002, unpaired t-test). Immunophenotyping performed on the CD4 and CD8 T lymphocytes showed a propensity for memory cells to undergo proliferation. We also found individuals with SCD had higher turnover in TCR sequences in two timepoints compared to healthy donors (p=0.05, Chi-square). Notably, we also saw increased proliferation of B cells, NK cells, macrophages, and dendritic cells in individuals with SCD. Conclusion Our data suggest that T lymphocytes and other PBMCs undergo faster turnover in SCD than in healthy donors, suggesting a stronger hematopoietic drive. Our findings may have important implications for gene therapy since an increased proliferative driv
doi_str_mv 10.1182/blood-2023-187292
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2023_187292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497123118763</els_id><sourcerecordid>S0006497123118763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1372-4e5698e59d118a2e330fbe8e577f17da919842900fbef1470684e29722c828d73</originalsourceid><addsrcrecordid>eNp9kN1KAzEQhYMoWKsP4F1eIDqZ3W0SvJKtP4WCgnodtskEo9umJKXQt3fXeu3NDBz4DoePsWsJN1JqvF31KXmBgJWQWqHBEzaRDWoBgHDKJgAwE7VR8pxdlPIFIOsKmwlrFxuXqSvk-WtOfQyUu13cE5_n8abAl4f19jO5w44Kjxv-Ft13T7ylvufzWEb0kp2Fri909fen7OPx4b19FsuXp0V7vxROVgpFTc3MaGqMHxZ3SFUFYUVDoFSQyndGGl2jgTENslYw0zWhUYhOo_aqmjJ57HU5lZIp2G2O6y4frAQ7WrC_FuxowR4tDMzdkaFh2D5StsVF2jjyMZPbWZ_iP_QPxlRj8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Increased Proliferative Drive of Lymphocytes in Sickle Cell Disease</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ginda, Ashley ; Zhang, Jingyue ; Meng, Wenzhao ; Kearns, Charlotte ; Weissman, Samuel ; Swiggard, Liam ; Richards, Clarice ; Moore, Jeffrey ; Murter, Melissa ; Luning Prak, Eline T. ; O'Doherty, Una</creator><creatorcontrib>Ginda, Ashley ; Zhang, Jingyue ; Meng, Wenzhao ; Kearns, Charlotte ; Weissman, Samuel ; Swiggard, Liam ; Richards, Clarice ; Moore, Jeffrey ; Murter, Melissa ; Luning Prak, Eline T. ; O'Doherty, Una</creatorcontrib><description>Introduction Patients with sickle cell disease (SCD) have higher levels of inflammation which plays a prominent role in disease pathogenesis. It is well known that individuals with SCD have a higher erythropoietic drive given the ~20 day life span of their red blood cells. We asked whether this increased proliferative drive also occurred in white blood cells (WBC). To characterize WBC turnover we focused on the longest-lived CD4+ and CD8+ T cells. Methods Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient from red cell waste products from consented individuals with sickle cell disease and from leukapheresis products of healthy donors. In ten healthy donors and ten donors with SCD, CD4 and CD8 T cells were purified using EasySep Cell Isolation, labeled with eFluor 670 proliferation dye, and cultured in RPMI with 30% FBS for seven days. Samples were collected daily and stained with naïve and memory T cell markers. CountBright beads were added to obtain absolute cell counts and eFluor 780 live/dead dye was used to capture daily snapshots of cell death. Flow cytometric analysis was performed to track absolute cell numbers, cell division and indirectly monitor cell death. B cells, NK, macrophages, and dendritic cells were similarly tracked. To further probe T cell turnover, T cell receptor (TCR) sequencing was performed on twelve separate aliquots from purified CD4+ T cells at two different timepoints in healthy donors and individuals with SCD. Turnover of clonal sequences was analyzed using the Morisita index. Results CD4+ and CD8+ lymphocytes from individuals with SCD experienced more death in culture by day 7 compared to healthy donor controls. In addition, T lymphocytes from donors with SCD were observed to undergo 15-fold more proliferation compared to healthy donors (p=0.0002, unpaired t-test). Immunophenotyping performed on the CD4 and CD8 T lymphocytes showed a propensity for memory cells to undergo proliferation. We also found individuals with SCD had higher turnover in TCR sequences in two timepoints compared to healthy donors (p=0.05, Chi-square). Notably, we also saw increased proliferation of B cells, NK cells, macrophages, and dendritic cells in individuals with SCD. Conclusion Our data suggest that T lymphocytes and other PBMCs undergo faster turnover in SCD than in healthy donors, suggesting a stronger hematopoietic drive. Our findings may have important implications for gene therapy since an increased proliferative drive may contribute to an increased risk of developing leukemia in SCD. No relevant conflicts of interest to declare. [Display omitted]</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2023-187292</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2023-11, Vol.142 (Supplement 1), p.5275-5275</ispartof><rights>2023 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ginda, Ashley</creatorcontrib><creatorcontrib>Zhang, Jingyue</creatorcontrib><creatorcontrib>Meng, Wenzhao</creatorcontrib><creatorcontrib>Kearns, Charlotte</creatorcontrib><creatorcontrib>Weissman, Samuel</creatorcontrib><creatorcontrib>Swiggard, Liam</creatorcontrib><creatorcontrib>Richards, Clarice</creatorcontrib><creatorcontrib>Moore, Jeffrey</creatorcontrib><creatorcontrib>Murter, Melissa</creatorcontrib><creatorcontrib>Luning Prak, Eline T.</creatorcontrib><creatorcontrib>O'Doherty, Una</creatorcontrib><title>Increased Proliferative Drive of Lymphocytes in Sickle Cell Disease</title><title>Blood</title><description>Introduction Patients with sickle cell disease (SCD) have higher levels of inflammation which plays a prominent role in disease pathogenesis. It is well known that individuals with SCD have a higher erythropoietic drive given the ~20 day life span of their red blood cells. We asked whether this increased proliferative drive also occurred in white blood cells (WBC). To characterize WBC turnover we focused on the longest-lived CD4+ and CD8+ T cells. Methods Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient from red cell waste products from consented individuals with sickle cell disease and from leukapheresis products of healthy donors. In ten healthy donors and ten donors with SCD, CD4 and CD8 T cells were purified using EasySep Cell Isolation, labeled with eFluor 670 proliferation dye, and cultured in RPMI with 30% FBS for seven days. Samples were collected daily and stained with naïve and memory T cell markers. CountBright beads were added to obtain absolute cell counts and eFluor 780 live/dead dye was used to capture daily snapshots of cell death. Flow cytometric analysis was performed to track absolute cell numbers, cell division and indirectly monitor cell death. B cells, NK, macrophages, and dendritic cells were similarly tracked. To further probe T cell turnover, T cell receptor (TCR) sequencing was performed on twelve separate aliquots from purified CD4+ T cells at two different timepoints in healthy donors and individuals with SCD. Turnover of clonal sequences was analyzed using the Morisita index. Results CD4+ and CD8+ lymphocytes from individuals with SCD experienced more death in culture by day 7 compared to healthy donor controls. In addition, T lymphocytes from donors with SCD were observed to undergo 15-fold more proliferation compared to healthy donors (p=0.0002, unpaired t-test). Immunophenotyping performed on the CD4 and CD8 T lymphocytes showed a propensity for memory cells to undergo proliferation. We also found individuals with SCD had higher turnover in TCR sequences in two timepoints compared to healthy donors (p=0.05, Chi-square). Notably, we also saw increased proliferation of B cells, NK cells, macrophages, and dendritic cells in individuals with SCD. Conclusion Our data suggest that T lymphocytes and other PBMCs undergo faster turnover in SCD than in healthy donors, suggesting a stronger hematopoietic drive. Our findings may have important implications for gene therapy since an increased proliferative drive may contribute to an increased risk of developing leukemia in SCD. No relevant conflicts of interest to declare. [Display omitted]</description><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kN1KAzEQhYMoWKsP4F1eIDqZ3W0SvJKtP4WCgnodtskEo9umJKXQt3fXeu3NDBz4DoePsWsJN1JqvF31KXmBgJWQWqHBEzaRDWoBgHDKJgAwE7VR8pxdlPIFIOsKmwlrFxuXqSvk-WtOfQyUu13cE5_n8abAl4f19jO5w44Kjxv-Ft13T7ylvufzWEb0kp2Fri909fen7OPx4b19FsuXp0V7vxROVgpFTc3MaGqMHxZ3SFUFYUVDoFSQyndGGl2jgTENslYw0zWhUYhOo_aqmjJ57HU5lZIp2G2O6y4frAQ7WrC_FuxowR4tDMzdkaFh2D5StsVF2jjyMZPbWZ_iP_QPxlRj8A</recordid><startdate>20231102</startdate><enddate>20231102</enddate><creator>Ginda, Ashley</creator><creator>Zhang, Jingyue</creator><creator>Meng, Wenzhao</creator><creator>Kearns, Charlotte</creator><creator>Weissman, Samuel</creator><creator>Swiggard, Liam</creator><creator>Richards, Clarice</creator><creator>Moore, Jeffrey</creator><creator>Murter, Melissa</creator><creator>Luning Prak, Eline T.</creator><creator>O'Doherty, Una</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20231102</creationdate><title>Increased Proliferative Drive of Lymphocytes in Sickle Cell Disease</title><author>Ginda, Ashley ; Zhang, Jingyue ; Meng, Wenzhao ; Kearns, Charlotte ; Weissman, Samuel ; Swiggard, Liam ; Richards, Clarice ; Moore, Jeffrey ; Murter, Melissa ; Luning Prak, Eline T. ; O'Doherty, Una</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1372-4e5698e59d118a2e330fbe8e577f17da919842900fbef1470684e29722c828d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ginda, Ashley</creatorcontrib><creatorcontrib>Zhang, Jingyue</creatorcontrib><creatorcontrib>Meng, Wenzhao</creatorcontrib><creatorcontrib>Kearns, Charlotte</creatorcontrib><creatorcontrib>Weissman, Samuel</creatorcontrib><creatorcontrib>Swiggard, Liam</creatorcontrib><creatorcontrib>Richards, Clarice</creatorcontrib><creatorcontrib>Moore, Jeffrey</creatorcontrib><creatorcontrib>Murter, Melissa</creatorcontrib><creatorcontrib>Luning Prak, Eline T.</creatorcontrib><creatorcontrib>O'Doherty, Una</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ginda, Ashley</au><au>Zhang, Jingyue</au><au>Meng, Wenzhao</au><au>Kearns, Charlotte</au><au>Weissman, Samuel</au><au>Swiggard, Liam</au><au>Richards, Clarice</au><au>Moore, Jeffrey</au><au>Murter, Melissa</au><au>Luning Prak, Eline T.</au><au>O'Doherty, Una</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Proliferative Drive of Lymphocytes in Sickle Cell Disease</atitle><jtitle>Blood</jtitle><date>2023-11-02</date><risdate>2023</risdate><volume>142</volume><issue>Supplement 1</issue><spage>5275</spage><epage>5275</epage><pages>5275-5275</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Introduction Patients with sickle cell disease (SCD) have higher levels of inflammation which plays a prominent role in disease pathogenesis. It is well known that individuals with SCD have a higher erythropoietic drive given the ~20 day life span of their red blood cells. We asked whether this increased proliferative drive also occurred in white blood cells (WBC). To characterize WBC turnover we focused on the longest-lived CD4+ and CD8+ T cells. Methods Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient from red cell waste products from consented individuals with sickle cell disease and from leukapheresis products of healthy donors. In ten healthy donors and ten donors with SCD, CD4 and CD8 T cells were purified using EasySep Cell Isolation, labeled with eFluor 670 proliferation dye, and cultured in RPMI with 30% FBS for seven days. Samples were collected daily and stained with naïve and memory T cell markers. CountBright beads were added to obtain absolute cell counts and eFluor 780 live/dead dye was used to capture daily snapshots of cell death. Flow cytometric analysis was performed to track absolute cell numbers, cell division and indirectly monitor cell death. B cells, NK, macrophages, and dendritic cells were similarly tracked. To further probe T cell turnover, T cell receptor (TCR) sequencing was performed on twelve separate aliquots from purified CD4+ T cells at two different timepoints in healthy donors and individuals with SCD. Turnover of clonal sequences was analyzed using the Morisita index. Results CD4+ and CD8+ lymphocytes from individuals with SCD experienced more death in culture by day 7 compared to healthy donor controls. In addition, T lymphocytes from donors with SCD were observed to undergo 15-fold more proliferation compared to healthy donors (p=0.0002, unpaired t-test). Immunophenotyping performed on the CD4 and CD8 T lymphocytes showed a propensity for memory cells to undergo proliferation. We also found individuals with SCD had higher turnover in TCR sequences in two timepoints compared to healthy donors (p=0.05, Chi-square). Notably, we also saw increased proliferation of B cells, NK cells, macrophages, and dendritic cells in individuals with SCD. Conclusion Our data suggest that T lymphocytes and other PBMCs undergo faster turnover in SCD than in healthy donors, suggesting a stronger hematopoietic drive. Our findings may have important implications for gene therapy since an increased proliferative drive may contribute to an increased risk of developing leukemia in SCD. No relevant conflicts of interest to declare. [Display omitted]</abstract><pub>Elsevier Inc</pub><doi>10.1182/blood-2023-187292</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2023-11, Vol.142 (Supplement 1), p.5275-5275
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2023_187292
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Increased Proliferative Drive of Lymphocytes in Sickle Cell Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T07%3A53%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Proliferative%20Drive%20of%20Lymphocytes%20in%20Sickle%20Cell%20Disease&rft.jtitle=Blood&rft.au=Ginda,%20Ashley&rft.date=2023-11-02&rft.volume=142&rft.issue=Supplement%201&rft.spage=5275&rft.epage=5275&rft.pages=5275-5275&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2023-187292&rft_dat=%3Celsevier_cross%3ES0006497123118763%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497123118763&rfr_iscdi=true